Co-Founder, Dr. Edwards brings to bear combined medical, business, and scientific expertise as CEO of US Authentic Trading Company.

• Expert at introducing complex healthcare brands, services, and technologies into the PRC economy having successfully navigated international regulatory compliance issues across a broad spectrum including commerce, services, & virtual communications software platforms, National Public Health linked & integrated projects, and laboratory, surgical, & medical products and technologies sold directly to hospital systems, facilities, and institutions.

• BS Molecular Biophysics and Biochemistry and Economics: Yale College, 1986-1990

  MD PhD: National Institute of Health (NIH) Medical Scientist Training Program (MSTP), 1990-1999

  PhD Human and Molecular Genetics, Discovery of Cyclin K and Biochemical Characterization

  Thesis Advisor: Stephen J. Elledge Professor of Genetics Harvard Medical School

  Residency and Fellowship: Integrated Plastic and Reconstructive Surgery Program Baylor College of Medicine, Texas Medical Center, 1999-2005

  Discovered and Developed Intra-operative Nerve Monitoring based Neuropathy Microsurgery, 2005-2007

  Founder of Foundation for the Permanent Elimination of Nerve Pain and Disability, 2007 to present

  Founder of Mobil Medical Records Association: First Human Data Sovereignty Non-Profit, 2011 to present

  Founder of Gravity Healthcare: Disruptive Healthcare Data Platform partnered with Wistron (www.Wistron.com ), 2012 to present

  Advisor Chinese Central Government in Healthcare and Public Health, 2015 to present 

• Chairman
  USAT-Unihealth Medical Technology Display Center
• Founder
  Unihealth brand
• President
  Shanghai Unihealth Pharmaceutical International Trade Co., Ltd.
• President
  Shanghai Nuowente Medical Science and Technology Co., Ltd.
• Senior Advisory
  U.S. Medical Technology Association
• Advisory
  Nordic Business House Senior
• Supervisor
  Shanghai Association for Science and Technology
• Expert
  Shanghai Academician Expert Science Popular Annotator's Guiding Group

• RN, BSN
• Principal Consultant at Health & Retail Consulting, LLC
• Project Manager/Client Relationship Manager, Origenetics, LLC.
• Associate/Executive Assistant, Fields Texas Limited
• Former Outpatient and Inpatient Cardiovascular Re-hab Clinician, Mississippi Baptist Medical Center 
• Former Charge/Staff RN, Cardio Intensive Care/Recovery, Mississippi Baptist Medical Center
• Former Staff and Charge Nurse in the Oncology Unit at Wesley Medical Center 
• Recipient of the Grady and Aileen McCool Scholarship, Mended Hearts Chapter 76, for outstanding nursing in cardiac field

• Partner, US Authentic Trading Company
• RN, BSN, Diplomat, ABAAHP Fellow, Stem Cells ABAARM
• Managing Director of Origenetics, LLC, and FutureHealth Alliance, LLC. 
• Served on staff of Mississippi Baptist Medical Center as a Staff/Charge nurse of the Cardiovascular Intensive Care and Recovery Unit
• Established one of the first ambulatory infusion centers to provide chemotherapy services to cancer patients outside of a hospital setting. 
• Obtained her Certified Registered Nurse Intravenous (CRNI) certification 
• First R.N. to complete a Fellowship of Stem Cell Medicine from the American Academy of Anti-aging and Regenerative Medicine.\
• Served as a Director for Four Corners Sourcing, LLC, a sourcing and product development company based in China, representing retail and manufacturing clients in North America and Europe with a global staff of more than 100 employees, facilities around the world, and a leadership team experienced in the areas of product development and marketing.
• Lucia also serves as a Director for Fields Texas Limited, LLC

• Executive Director of the Institute of Regenerative and Cellular Medicine,
  and Chair of the IRCM IRB, which provides support for translational
  research and validation of regenerative therapies.
• CEO of Humanity Fund/A3Cell consultancy, for 25+ years has provided
  support for biomedical start-up companies.
• Chief of Scientific Affairs for Lipogems US, Dr. Krutchkoff successfully
  navigated regulatory pathway and gain US FDA approval, find funding and
  national distribution for an international start-up.
• Currently serves as advisory board member of a number of companies
  including; Personalized Stem Cells, RareCells, Klotho Therapeutics, DaVinci
  Center.
• Board Certified Diplomat and Fellow of the American Academy and Board
  of Regenerative Medicine (AABRM).
• Stem Cell Fellow American Academy of Anti-Aging Medicine (A4M).
• Post Doc/Stem Cell Fellowship at Bruno Peault lab, UCLA.
• Graduate studies in Biomedical Engineering.
• Doctorate in Functional Medicine.
• Adjunct Lecturer at Universite Paris Descartes.
• Design and oversight of over 400 clinical studies.

• Branding and Corporate Messaging Consultant at Shecansell,com
• Professor, Visual Communications, Graphic Media Production, ACC
• Marketing/Creative for Fields TX, LLC, FutureHealth Alliance, and Origenetics, LLC
• Former Vice President of Sales, Training and Business Development at PRIMEDIA

• Vice Chairman and Director
  China Medical Education Association Medical Digital Education Committee

• President, JP
  Australia China Culture & Education Exchange Centre Pty Ltd (ACCEEC)

• Former Director
  Shanghai Municipal Food and Drug Administration  Certification and Evaluation Center
• Vice President
  Shanghai Licensed Pharmacist Association
• Chief Representative
  Shanghai Municipal Food and Drug Administration in the Free Trade Zone

• USAT-Unihealth Medical Technology Display Center Operation Management Team

• Former Department Head
  Medical Device Supervision Department of Shanghai Municipal Food and Drug Administration
• Professor
  Advanced Research Institute of China Food and Drug Administration

• Former Deputy Director, Bureau Level Inspector
  Shanghai Municipal Food and Drug Administration
• Visiting Professor
  Shanghai Jiao Tong University

• Former Director
  International Cooperation Department of China Food and Drug Administration
• Honorary Director
  China Center For Pharmaceutical International Exchange

• Chairman
  Shanghai Sun flower Public Welfare Foundation

• USAT-Unihealth Medical Technology Display Center Expert Advisory Team
• Former Director
  Trade Administration Office of the Ministry of Commerce, PRC

Co-founder of two successful companies in Papa Chau Foods and Vita Canyon, Harrison Chau is a distinguished graduate of the W.P. Carey School of Business. A keen strategic thinker, Mr. Chau specializes in performance improvement and has previously consulted with small and mid-cap companies as well as emerging startups across all stages of company growth in the areas of work management, operations improvement, technology-enabled business transformation, business case analytics and program management.

• Board Member
  US Authentic Trading Company

• USAT-Unihealth Medical Technology Display Center Operation Management Team

• USAT-Unihealth Medical Technology Display Center Operation Management Team

• USAT-Unihealth Medical Technology Display Center Operation Management Team

• USAT-Unihealth Medical Technology Display Center Operation Management Team
• Certified Practicing Attorney
• Member of Shanghai Attorneys Association
• Director of “Exhibition Law Practice” Research Center

• USAT-Unihealth Medical Technology Display Center Operation
  Management Team
• Shanghai Nuowente Medical Science and Technology Co., Ltd. CEO
• Licensed Pharmacist

Richard Chau is a non-executive Co-Founder of US Authentic. a US Citizen

• Mr. Chau has successfully owned and operated multiple international hotels in Vietnam as well as a multitude of other businesses since the early 1990’s. From 2003 to 2008 he was CEO of Equitable Investment Group, LLC, which developed luxury residential real estate in California. Since 2004, Mr. Chau has been the owner and CEO of Truong That Co., a commercial and residential real estate development company in Vietnam.
• Highly sought out for his integrity and vast Asian Rolodex, Mr. Chau has consulted with major global corporations and many ultra-high net worth individuals as they enter into the Asia market from the West or into the US market from the East.